Arun specializes in global product strategy through every stage of the product lifecycle, launch planning, marketing, market research, market and/or therapeutic area assessments, and due diligence of business development/licensing opportunities for pharma-biotech companies.  

Prior to founding MediSen Consulting LLC, he was the Executive Director, Global Product Strategy at Jazz Pharmaceuticals. During his tenure at Jazz, Arun secured funding for and led the multi-disciplinary team responsible for initiating and managing development of two indications in neuroscience with suvecaltamide (JZP385). He was also instrumental in initiating a drug discovery program at Jazz using acquired molecular scaffolds. Prior to joining Jazz, Arun provided commercial leadership to several Phase 3 indications for KEVZARA® (sarilumab) and for romilkimab (bispecific antibody) in rheumatology at Sanofi. Earlier in his career, Arun was responsible for the end-to-end HCP strategy development for EVENITY at Amgen, held several roles in Marketing and in New Product Licensing at Merck, and spent several years working at Merck as a market researcher.

Arun earned a Bachelor of Science in Biochemistry & Molecular Biology from the University of California at Santa Barbara, and a Master of Business Administration degree from UCLA. Since 2023, he has been working on a Master of Science degree in Drug Discovery & Development at Drexel University.